1. Home
  2. AGIO vs NSSC Comparison

AGIO vs NSSC Comparison

Compare AGIO & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.95

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$44.51

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
NSSC
Founded
2007
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AGIO
NSSC
Price
$27.95
$44.51
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$36.63
$48.17
AVG Volume (30 Days)
881.5K
551.2K
Earning Date
02-12-2026
02-02-2026
Dividend Yield
N/A
1.36%
EPS Growth
N/A
0.75
EPS
N/A
1.32
Revenue
$54,028,000.00
$192,025,000.00
Revenue This Year
$104.62
$13.32
Revenue Next Year
$125.15
$9.84
P/E Ratio
N/A
$33.45
Revenue Growth
48.03
2.94
52 Week Low
$22.24
$19.00
52 Week High
$46.00
$48.12

Technical Indicators

Market Signals
Indicator
AGIO
NSSC
Relative Strength Index (RSI) 54.94 58.11
Support Level $26.05 $41.31
Resistance Level $29.93 $44.50
Average True Range (ATR) 1.18 1.77
MACD 0.10 0.32
Stochastic Oscillator 62.47 75.18

Price Performance

Historical Comparison
AGIO
NSSC

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: